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Introduction 
Medicines are prescribed for patients, usually appropriately, in response to illness and symptoms. 
Many are continued for life, especially when prescribed for chronic conditions. With increasing age, 
some medicines, particularly those requiring adequate organ function for drug clearance, can 
produce more harm than benefit. Research shows that high risk prescribing increases with the 
number of medicines, and that patients prescribed five or fewer medicines are less likely to present 
to hospital with adverse events.1,2  Polypharmacy can be appropriate with increasing morbidities in 
older age, but regular review is needed to ensure that each medicine is still appropriate, based on 
clear outcomes.  We have recently described our experience of reviewing, holding and stopping 
medicines in the rehabilitation setting using the North West London STOPIT tool.3 Here, we describe 
our early experience of adapting the Screening Tool for Older People’s Inappropriate Treatments 
(STOPIT), including specific consideration of anticholinergic burden, for use in the outpatient setting.  
This was a service improvement pilot to explore the practicalities and challenges of deprescribing for 
elderly outpatients at the Chelsea and Westminster Hospital NHS Foundation Trust (CWFT). 
STOPIT in the rehabilitation setting and our plans for outpatients 
The STOPIT tool was adapted for use at the CWFT from the Improving Prescribing for the Elderly 
(ImPE) tool, used at Imperial College Healthcare Trust,4 a medication review pro forma derived from 
the validated evidence-based STOPP tool (Screening Tool of Older Persons potentially inappropriate 
Prescriptions).2  The primary aim of stopping medicines is prevention of harm in susceptible patients.  
Both STOPIT and ImPE projects are supported by the National Institute of Health Research 
Collaboration for Leadership in Applied Health Research and Care Northwest London (NIHR CLAHRC 
NWL).  
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As part of our STOPIT initiatives, we found the Medicine for the Elderly rehabilitation unit to be an 
ideal setting for changing doses or stopping medicines that were considered to be causing harm with 
little or no benefit.3  We could monitor the effects of the prescription changes by temporarily halting 
and then reintroducing at modified doses or stopping permanently.  Changes were discussed with 
patients and relatives as appropriate. 
Our subsequent objectives included exploring the use of STOPIT in the outpatient setting, because of 
the opportunity to ‘capture’ patients who may not otherwise have presented to their GP or 
community pharmacy, with the aim of this work to gain early experience of the practicalities and 
challenges of medication review in outpatients; and to make recommendations for further study on 
medication review in the outpatient setting. This paper addresses that aim.   
 
Method  
A local ethics waiver was obtained for this service evaluation, since this was an extension of 
previously approved work. 
Adaptations to the STOPIT tool: 
Two key adaptations were made.  Firstly, the STOPIT pro forma for outpatients (Appendix 1) now 
includes a section about how the medication history could be checked.   From our experience, 
patients sometimes expect that the hospital clinic has a current list of their GP’s repeat medicines, 
which is not the case.  
Secondly, we adapted and used work relating to the ‘anticholinergic burden’ (ACB)5 that is likely to 
affect many of our elderly patients.  When taken concomitantly, anticholinergic medicines may 
cause additive adverse effects and present a greater risk. In the outpatient setting, it was 
hypothesised that an ACB medication list would complement STOPIT in helping the doctor working 
alone within the time constraints of the current outpatient setting.   
Data collection: 
A consultant and registrar (IB and SD) in Medicine for the Elderly collected data prospectively and 
consecutively for patients seen between January and April 2014.  This four month period was the 
available evaluation period for SD to be in clinic.  Using STOPIT and the adapted ACB table, data was 
recorded on a pro forma, including details of each presenting patient’s current medication, how the 
list was confirmed, and what was stopped or altered during the consultation. The post-clinic letter to 
the GP contained details about any medication changes made.  It is important to emphasise that the 
use of STOPIT criteria is only possible following reliable medicines reconciliation. 
Data Analysis: 
Descriptive statistics were used to define patient demographics, the number of medicines taken and 
those that were changed. Comparisons were made between groups (genders), using chi-square 
testing.   
Results 
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Demographic summary: 
From 112 outpatient appointments during our study period, 101 patients were recruited, 11 of 
whom were seen twice. Patients were assessed using the pro forma as part of our service 
improvement pilot. The majority of patients were accompanied by a family member or friend.  The 
mean age of patients was 84 (range 71 to 99) years (figure 1); with 51 female (66%) and 26 male 
patients reviewed.  
Figure 1: A histogram of ages of patients reviewed - January to April 2014 
 
Establishing the medication history in outpatients: 
In 25/112 (22%) appointments, the patient’s current list of medicines could not be checked, so a 
medication review could not be undertaken. Seventy-seven patients had 87 reviews within the 112 
appointments.   
The source of the medication history taken is categorised as follows: 23 histories were taken from 
memory (or that of the patient’s accompanying carer, family member or friend); 14 patients had 
their GP prescription repeat slip, 1 had a GP-typed list, 2 had clinic letters, 15 brought their 
medicines containers with them (11 were multi-compartment compliance aids (MCAs)). A further 14 
had their ‘own’ lists, which were their own self-typed or handwritten lists. Medication 
Administration Record (MAR) charts from nursing homes were available for 3 patients and 3 had 
discharge summaries (‘DSUM’) available on the hospital system that were recent and still valid. Two 
sources were not recorded. Table 1 includes the source of the medicines history for those patients 
where medicines were altered following review in clinic, and shows the numbers of medicines being 
taken by each patient. 
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Table 1. Source of the Medication History for patients, where medicines were altered. 
Patient 
number Age Gender Source 
Number of medicines in the 
medication history 
1 71 F Not recorded 4 
2 83 F FP10 6 
3 90 F FP10 14 
4 87 F Not recorded 10 
5 87 F Not recorded 12 
6 79 M Not recorded 9 
7 80 M Not recorded 9 
8 83 F Original boxes 4 
9 72 F From memory 4 
10 79 F DSUM 9 
11 79 F From memory 3 
12 76 F FP10 8 
13 79 M Not recorded 15 
14 89 F MCA 9 
15 78 F FP10 13 
16 86 F Own list 9 
17 78 F Not recorded 6 
18 74 M From memory 7 
19 90 F MCA 6 
20 86 F MCA 5 
21 91 F Own list 11 
22 97 M MAR 12 
23 75 M MCA 8 
24 90 F MCA 6 
 
Medication review in elderly outpatients 
Eighty-seven full medication reviews with 77 patients were completed during the study period. Our 
patients had a broad range of co-morbidities. The purpose of the review was a structured, critical 
examination of current prescription with the patient to optimise the impact of medicines, minimise 
medication-related problems and reduce waste.  Twenty-four patients had changes made to one or 
more medicines (24/101 reviews, 24%).  The remaining patients were reviewed and medication was 
deemed appropriate with no need to change. There was no difference by gender in the source for 
the current medication  (χ22=2.602, p=0.272), or the likelihood of medicines being changed 
(χ21=3.557, p=0.059). 3 patients (4% of reviewed) were on no medicines and no changes were made. 
One patient was taking one medicine that was stopped and so was left taking no medicines.  Of the 
eleven patients who returned to clinic within the study period, two returned on no medicines and 
remained on zero.  In 9 of the 87 reviews, patients (one already on nil medications) attended 
outpatients specifically for the falls clinic. The dose of the analgesic tramadol was reduced in one 
patient; and one the antihypertensive dose of bisoprolol was reduced and ramipril added in another.  
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The total number of medicines known to be taken by the 77 reviewed patients was 538; a mean of 7 
per patient, ranging from 0 to 21. 26 of the 538 medicines (4.8%) were eye drops for glaucoma and 
other chronic eye conditions that the doctor in this clinic would not be expected to review but would 
need to take into account when considering other systemic medicines.  34 medicines in total (7%) 
were stopped during the study period. 3 of these medicines in 3 different patients were not 
permanently stopped but ‘held’ pending further review in clinic (Adcal, alendronate and allopurinol). 
A further 10 medicines were altered (rather than stopped) on review in clinic: a lower dose in 6 cases 
(one medicine in each case); switched to an alternative in 2 cases (omeprazole to ranitidine, aspirin 
to rivaroxaban); and 2 patients had a medicine started (one restarted on lorazepam).  All other 
medicines were reviewed but not altered. The medicines altered during the review  for 24 patients 
and  43 medicines are presented in Table 2. 
Table 2: the medications altered during review in an outpatient setting:  
Patient no Intervention Medicine 
1 Stop Indapamide 
2 stop Cetirizine 
2 reduce Simvastatin 
3 hold Alendronate 
4 stop Quinine 
5 stop Amlodipine 
5 stop Rivaroxaban 
5 stop Lactulose 
5 stop Co-codamol (2 ingredients - paracetamol/codeine) 
6 stop Tamsulosin 
7 stop Solifenacin 
7 switch Change omeprazole to ranitidine 
8 switch Change aspirin to rivaroxaban 
9 stop HRT 
10 stop Quinine 
11 stop Arthrotec® (2 ingredients) counted once 
12 stop Iron 
12 reduce Omeprazole 
13 stop Digoxin 
13 hold Allopurinol 
14 reduce Tramadol 
15 stop Solifenacin 
15 reduce Bisoprolol 
16 stop Aspirin 
16 stop Amlodipine 
16 stop Adcal® (2 ingredients) counted once 
16 stop Tolterodine 
17 stop Solifenacin  
18 stop Omeprazole 
18 stop Diclofenac 
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19 stop Ranitidine 
19 stop Cetirizine 
20 reduce Mirtazapine 
21 increase Mirtazapine 
21 stop Paracetamol 
21 hold Adcal® (2 ingredients) counted once 
22 stop Codeine 
22 restart Lorazepam 
23 reduce Bisoprolol 
23 start Ramipril 
24 stop Iron 
24 stop Folic acid 
 
Discussion 
The results of this service-improvement indicate value in outpatient medication review activity, as 
does other work around decreasing the medication burden in community-dwelling elderly patients.6 
Our interventions were made by experienced physicians who are confident in undertaking 
medication reviews. It was only possible to stop medicines in 24 patients (24% of the cohort, or 31% 
of those reviewed). Nevertheless, for some it was an  opportunity to reduce medication burden.  For 
example, one patient who had brought her own medicines with her had 4/9 medicines stopped. 
The availability of the adapted STOPIT pro forma and the ACB list5 were helpful in the outpatient 
setting for speeding up the review process, with value as a quick reference source. Senior staff are 
familiar with the content and we postulate that more junior doctors would also find these tools 
valuable for their early medication reviews, particularly given that physicians may be reluctant to 
review decisions or discontinue or change drug regimens determined by “experts” or from 
guidelines for younger populations.6 Focus groups at CWFT have previously suggested that junior 
doctors feel uncomfortable stopping medicines that more senior doctors have initiated.3   
Although outpatient time slots are longer in elderly medicine clinics, the time available for a 
thorough medication review was a limiting factor including recording the review undertaken in the 
medical file for a subsequent physician, explaining the reasons for changes to the patient and 
communicating with GPs via a dictated letter.  Duplication of medical records is not an issue unique 
to CWFT. 
Changes to medication made in an outpatient appointment may not always be followed through in 
the community setting and should be subject to further study. There are known to be multiple 
reasons for this, including inaccurate information or medication lists being provided in the first 
instance, the outpatient letter not being received or acted on by the GP for various reasons, or the 
patient themselves not following recommended changes.  Hence, real time communication with GPs 
would be invaluable.   
The CWFT Trust invitation letter for an outpatient appointment specifically requests that patients 
bring their medication with them, but the letter may be received well in advance of the appointment 
and in some cases, patients did not receive a letter but only a reminder telephone call the day 
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before the appointment.  In this patient cohort, some forgot to bring an up-to-date list.  Outpatient 
receptionists were instructed to remind patients to bring medications with them at the time of the 
reminder telephone call, however not all patients could be reached. Further study in the area of 
communication with patients is needed so that improvements might be made in this part of the 
review process. 
24/101 patients had no medicines with them to use as a check, nothing documented, and were 
unable to give an account of their medication history  Important work is already underway in 
improving medicines reconciliation for inpatient admissions:  for example, an audit undertaken in 45 
English hospitals (including CWFT) provides evidence that medicines reconciliation at admission 
prevents adverse events during an inpatient stay.7 Therefore, for inpatients it is considered essential 
to have an accurate, verified record of current medication before prescribing or deprescribing. Part 
of this process requires fast and accurate links between primary and secondary care records that 
would improve the possibility for review in outpatient settings as well as in the community. 
Other challenges and limitations: 
We appreciate the limitations of this pilot and the challenges faced, which include the following: 
 The small sample size, short timescale and the lack of randomisation 
 The lack of a control makes it impossible to discern whether the changes made to medicines in 
clinic would have happened anyway without the adapted STOPIT tool and ACB table  
 The follow up period was just four months, meaning that some new patients may have 
medications changed in the future on a follow-up appointment in clinic 
Nevertheless, our experience indicates that: 
 Our reviews did not additionally burden the day-to-day activity of the clinic doctors 
 A medication review tool such as STOPIT can be used in this setting; and the effectiveness 
was augmented by specific consideration of the anticholinergic burden 
 Further study on the use of STOPIT in outpatients is warranted, including the effects on pill-
burden, medication costs and whether STOPIT makes it more likely that medicines will be 
reviewed 
 
Conclusion and recommendation 
We believe that medication review in the outpatient setting is worthwhile even if no medicines are 
stopped or changes made, providing the opportunity for discussion with patients/carers and 
communication with General Practitioners to promote ongoing review. We hope that others will 
consider the use of tools as an aid to medication review in the outpatient setting, so that a culture of 
reviewing medicines or prompting a review in all settings can develop.  We recommend that further 
work including larger studies is undertaken to explore quantitative aspects of medication review in 
the outpatient setting. 
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STOPIT:  
Screening Tool for Older People’s Potentially Inappropriate Treatments 
OUTPATIENT TOOL: please complete for all patients aged 70 years and above attending Outpatients 
Date of form 
 
 
Dr completing 
form (NAME) 
 
 
Patient sticker/ 
Hospital Number 
Start this form for all patients aged 70 
and over attending this clinic 
How many medicines is the patient 
taking regularly  
 
 
Include regular/“prn”, OTC medicines; 
short-course steroids/ antibiotics. 
Exclude nutritional supplements/topicals  
MEDICATION FOR REVIEW (as potentially inappropriate)  Patient’s own drugs seen? Yes [    ] No [    ] 
Medication Passport? [   ] /Other medication list?................................................................................ 
 
 
 
Is the patient on any of these 
medicines currently?  
N.B These medicines are more commonly 
hazardous in the elderly and may 
contribute to illness.  
Please tick all that apply 
 
 
 
 
 
   Diuretics 
   
Can cause falls and metabolic 
disturbances. 
   Anti-hypertensives  
   Other cardiac drugs/statins 
Can cause falls, metabolic/muscle 
disturbances and constipation (some) 
   Benzodiazepines>1month  
 
Can cause falls, confusion and sedation. 
   Opiate analgesics  
 
Can cause falls, confusion, sedation and 
constipation.  
   Oral anticoagulants (e.g.warfarin) 
   NSAIDs  (e.g. ibuprofen)  
   Antiplatelets 
Increase the risk of bleeding 
   Antipsychotics 
 
Can cause confusion/ sedation  
   Proton-pump Inhibitors 
   Antibiotics 
Linked with C diff and other adverse 
events especially in elderly. Is the course 
length appropriate/should be stopped? 
   Polypharmacy  Tick if the patient is on 6 or more 
medicines currently 
PROBLEMS POTENTIALLY ATTRIBUTABLE TO MEDICATION 
 
 
N.B. These symptoms/problems have been 
identified as potentially being medication-
related problems. 
Please tick all that apply 
 
 
 
   Falls including  postural 
hypotension,  impaired balance, 
dizziness 
Consider all falls-related drugs , and the 
anticholinergic burden (ACB) of current 
medicines* 
   Bleeding  Consider all drugs which increase the  risk 
of bleeding 
   Confusion/sedation  Consider all psychoactive drugs and the 
ACB* 
 
   Metabolic disturbance such as 
dehydration, renal impairment, 
electrolyte disturbance  
Consider diuretics, antidepressants, 
antihypertensives. 
   Constipation    Consider all opiate-related analgesics. 
Tick here if patient is already on a 
laxative   
 
* ACB: The anticholinergic burden (calculated from combinations of drugs with muscarinic action or 
side effects) may contribute to cognitive impairment, falls and fractures. 
References cited in: Using a MAP to steer patients away from medicines-related falls. Navila 
Chaudhry. Clinical Pharmacist 2013;5:119-121. 
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STOPIT Medication Review 
Drugs that can contribute to medication-related problems in the elderly 
 
Problem:  
 
Falls (including  postural 
hypotension,  impaired 
balance, dizziness) 
 
Antihypertensives 
Diuretics (e.g. amiloride) 
Bladder antimuscarinic drugs (e.g. oxybutynin) 
β-blocker eye drops (e.g. timolol) 
 
See also under Confusion and Sedation 
 
Problem: 
 
Confusion,  
Sedation 
SEDATION 
Benzodiazepines 
‘Z’ drugs (e.g. zopiclone, zopidem) 
Chlorals and derivatives 
Opioids and related drugs (e.g. tramadol) 
Sedating antihistamines 
Antipsychotics (e.g. haloperidol, olanzapine, quetiapine, risperidone, sulpiride) 
Centrally acting antihypertensives (.g. clonidine, Methyldopa) 
 
CONFUSION 
Opioids and related drugs (e.g. tramadol) 
Anticholinergics (e.g. procyclidine) 
Tricyclic antidepressants 
 
Problem:  
 
Bleeding 
  
  
Oral anticoagulant drugs (e.g. warfarin) 
Non-steroid anti-inflammatory drugs (NSAIDs) 
Antiplatelets 
Steroids 
 
Problem:  
 
Metabolic disturbance 
(such as dehydration, 
renal impairment, 
electrolyte disturbance) 
  
Diuretics (e.g. amiloride) 
ACE inhibitors  
ARBs (e.g. candesartan) 
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) 
Acetazolamide 
SSRIs (e.g. citalopram) 
Other antidepressants (e.g. mirtazapine, venlafaxine) 
Antiepileptic (e.g. carbamazapine) 
Donepezil 
Proton-pump inhibitors (PPIs) 
 
Problem: 
 
Constipation  
  
  
Opioids and related drugs (e.g. tramadol) 
Ferrous sulphate and related compounds  
Calcium resonium 
Tricyclic antidepressants  
Anticholinergics (e.g. procyclidine) 
Antispasmodics (e.g. hyoscine) 
Verapamil 
Bladder antimuscarinic drugs (e.g. oxybutynin) 
Antipsychotics (e.g. haloperidol, olanzapine, quetiapine, risperidone, sulpiride) 
 
Adapted from the STOPP Criteria : Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony 
D. Arch Intern Med. 2011;171(11):1013-1019 
